OR19-6 A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, Successfully Treats Graves’ Hyperthyroidism

Objective: Graves’ disease (GD) is an autoimmune disorder characterized by thyrotropin receptor autoantibody (TSHR-Ab)-mediated pathology, leading to hyperthyroidism. To date there is no pharmacotherapy that addresses the underlying pathogenesis. The CD40-CD154 (CD40L) co-stimulatory pathway plays a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Endocr Soc
Prif Awduron: Kahaly, George, Stan, Marius, Gergely, Peter, Colin, Laurence, Amer, Ahmed, Schuhmann, Imelda, Espie, Pascal, Rush, James, Basson, Craig, He, YanLing
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Endocrine Society 2019
Pynciau:
Thyroid
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554936/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-OR19-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg